Cancer known medically as a malignant neoplasm, is a broad group of various diseases, all involving unregulated cell growth. In cancer, cells divide and grow uncontrollably, forming malignant tumours, and invade nearby parts of the body. The cancer may also spread to more distant parts of the body. There are over 200 different known cancers that afflict humans. Cancer is the subject of widespread fear and taboos. There is a deep belief that cancer is necessarily a difficult and usually deadly disease.
Shilpa offers a comprehensive, high-quality portfolio and a dynamic pipeline of oncology drugs, which are beyond standard generics. We have a broad portfolio of 25 + products and a robust pipeline that addresses the needs of cancer treatment. By further growing our portfolio and strengthening our global presence, Shilpa will ensure that patients worldwide have greater access to a comprehensive range of these vital quality medicines at an affordable cost. We are proud to assert that the field of Oncology is one of our core competencies and we offer a comprehensive range of APIs and Finished Dosage Forms in this segment.
For more information on Shilpa‘s pipeline/products to treat cancer, Please find below Oncology product list.
|Oncology API||Tech Pack||DMF Status|
|Irinotecan HCl Trihydrate|
|Pemetrexed Disodium Hemipentahydrate|
|5- Fluoro Uracil|
|PRODUCTS UNDER DEVELOPMENT (Oncology)|
* PRODUCTS UNDER VALID PATENTS ARE NOT OFFERED FOR COMMERCIAL OPERATIONS:
ONLY R&D QUANTITIES ARE OFFERED.
For Enquiries, please contact